Smith Group Asset Management’s Novo Nordisk NVO Stock Holding History

Smith Group Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-62,072	Closed	-$1.8M	–	505
2015 Q4	$1.8M	Buy	62,072 +52,362	+539%	+$1.45M	0.05%	147
2015 Q3	$263K	Hold	9,710	–	–	0.01%	199
2015 Q2	$266K	Sell	9,710 -2,660	-22%	-$74.8K	0.01%	193
2015 Q1	$330K	Hold	12,370	–	–	0.01%	237
2014 Q4	$262K	Hold	12,370	–	–	0.01%	251
2014 Q3	$295K	Hold	12,370	–	–	0.01%	201
2014 Q2	$286K	Hold	12,370	–	–	0.01%	208
2014 Q1	$282K	Sell	12,370 -320	-3%	-$6.82K	0.01%	202
2013 Q4	$234K	Hold	12,690	–	–	0.01%	214
2013 Q3	$215K	Hold	12,690	–	–	0.01%	224
2013 Q2	$197K	Buy	+12,690	New	+$211K	0.01%	238

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Smith Group Asset Management's NVO Position: Q1 2016 in Review

Smith Group Asset Management sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 62,072 shares — an estimated $1.8M sold.

Smith Group Asset Management first reported a position in NVO in Q2 2013 and held it in 11 quarters. The position peaked at $1.8M in Q4 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Smith Group Asset Management reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
Smith Group Asset Management sold 62,072 Novo Nordisk shares in Q1 2016, an estimated $1.8M.
Smith Group Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 11 quarters.
Smith Group Asset Management's Novo Nordisk position peaked at $1.8M in Q4 2015.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Smith Group Asset Management's 13F filing for Q1 2016, filed 3 May 2016.